Publications by authors named "Francesco Ramundo"

Claim this Profile
E
Exploring thromboembolic risk factors in polycythemia vera: from current evidence to PROSPERO study design.
Valerio De Stefano, Francesco Passamonti, Francesca Palandri, Francesco Ramundo, Elena Rossi

Ann Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinician's knowledge and awareness of patient-reported outcomes in immune thrombocytopenia: Results of a national survey (ITP NET, GIMEMA Working Group Anemia and Thrombocytopenia).
Esther Natalie Oliva, Fabio Efficace, Maria Rosa Valvano, Paola Arcuri, Roberta Battistini, Francesco Ramundo

J Public Health Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the management of Polycythemia Vera patients eligible for cytoreduction: report of a multidisciplinary advisory board.
Francesco Ramundo, Elena Rossi, Ketty Peris, Alfredo Pontecorvi, Gabriele Sani

Curr Med Res Opin· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil/lymphocyte ratio identifies low-risk polycythaemia vera patients for early Ropeginterferon alfa-2b therapy.
Tiziano Barbui, Alessandra Carobbio, Paola Guglielmelli, Arianna Ghirardi, Francesca Fenili, Francesco Ramundo

Br J Haematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.
Tiziano Barbui, Alessandra Carobbio, Valerio De Stefano, Alberto Alvarez-Larran, Arianna Ghirardi, Francesco Ramundo

Ann Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera.
Alessandra Carobbio, Alessandro Maria Vannucchi, Valerio De Stefano, Arianna Masciulli, Paola Guglielmelli, Francesco Ramundo

Blood Cancer J· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome.
Paolo Gresele, Stefania Momi, Rossella Marcucci, Francesco Ramundo, Valerio De Stefano

Haematologica· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis.
Paola Guglielmelli, Giuseppe G Loscocco, Carmela Mannarelli, Elena Rossi, Francesco Mannelli, Francesco Ramundo

Blood Cancer J· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients.
Giuseppe G Loscocco, Paola Guglielmelli, Naseema Gangat, Elena Rossi, Carmela Mannarelli, Francesco Ramundo

Am J Hematol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients.
Silvia Bellesi, Elisabetta Metafuni, Stefan Hohaus, Elena Maiolo, Federica Marchionni, Francesco Ramundo

Br J Haematol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphological anomalies of circulating blood cells in COVID-19.
Gina Zini, Silvia Bellesi, Francesco Ramundo, Giuseppe d'Onofrio

Am J Hematol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis